Aimee Leigh Rowe, MD
Family Practice · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 3
Offices
3 locations · Lifelong Medical Care · Sutter Bay Medical Foundation · UCSF Medical Group Business Services
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rowe’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A163302 · Current
Licensed to practise in California · since 2019 · expires 2027-07-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$447,744 in 2024
Medicaid paid $447,744 for 3,383 billed services this clinician did in 2024, up to 113 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,334 | $446,945 |
| Return visit (30+ min) | 947 | $563 |
| Short return visit (20+ min) | 986 | $236 |
| Hemoglobin A1C level | 116 | $0 |
| 2024 | 3,383 | 4 | 113 | $447,744 |
| 2023 | 3,196 | 4 | 97 | $325,012 |
| 2022 | 2,011 | 3 | 84 | $178,579 |
| 2021 | 126 | 3 | 31 | $12,788 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,254 | $324,470 |
| Return visit (30+ min) | 733 | $362 |
| Short return visit (20+ min) | 1,151 | $180 |
| Hemoglobin A1C level | 58 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 728 | $177,887 |
| Short return visit (20+ min) | 831 | $397 |
| Return visit (30+ min) | 452 | $294 |
2021
| Clinic visit/encounter, all-inclusive | 53 | $12,713 |
| Return visit (30+ min) | 48 | $75 |
| Short return visit (20+ min) | 25 | $0 |
Drugs they prescribed that Part D paid
$230,162
Pharmacies billed $230,162 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (77 of 2,219) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 22% of their opioid prescriptions.
1,831 generic and fewer than 11 brand-name prescriptions · $230,162 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 67 | $65,113 | $972 |
| Jardiance | 31 | $34,299 | $1,106 |
| Albuterol Sulfate Hfa | 95 | $3,992 | $42 |
| Lantus Solostar | 13 | $2,325 | $179 |
| Diclofenac | 28 | $2,104 | $75 |
See all 51 drugs
| Ozempic | 67 | $65,113 | $972 |
| Jardiance | 31 | $34,299 | $1,106 |
| Albuterol Sulfate Hfa | 95 | $3,992 | $42 |
| Lantus Solostar | 13 | $2,325 | $179 |
| Diclofenac | 28 | $2,104 | $75 |
| Atorvastatin | 160 | $1,432 | $9 |
| Gabapentin | 39 | $939 | $24 |
| Hydrocodone-Acetaminophen | 49 | $928 | $19 |
| Ventolin Hfa | 12 | $801 | $67 |
| Ezetimibe | 11 | $745 | $68 |
| Metformin Hcl Er | 58 | $717 | $12 |
| Levetiracetam | 11 | $602 | $55 |
| Amlodipine Besylate | 96 | $592 | $6 |
| Potassium Chloride | 27 | $588 | $22 |
| Losartan | 63 | $549 | $9 |
| Pantoprazole | 30 | $538 | $18 |
| Tamsulosin | 33 | $508 | $15 |
| Fluticasone Propionate | 49 | $496 | $10 |
| Lisinopril | 70 | $479 | $7 |
| Ibuprofen | 47 | $444 | $9 |
| Metoprolol | 38 | $362 | $10 |
| Lisinopril-Hydrochlorothiazide | 35 | $357 | $10 |
| Metformin | 57 | $322 | $6 |
| Trazodone | 27 | $254 | $9 |
| Glipizide | 22 | $253 | $11 |
| Omeprazole | 35 | $235 | $7 |
| Chlorthalidone | 25 | $231 | $9 |
| Sertraline | 37 | $228 | $6 |
| Levothyroxine | 17 | $224 | $13 |
| Spironolactone | 23 | $215 | $9 |
| Pravastatin | 11 | $179 | $16 |
| Glipizide Er | 12 | $176 | $15 |
| Clopidogrel | 15 | $162 | $11 |
| Meclizine | 25 | $153 | $6 |
| Famotidine | 16 | $150 | $9 |
| Dilt-Xr | 12 | $142 | $12 |
| Cyclobenzaprine | 17 | $139 | $8 |
| Montelukast | 18 | $133 | $7 |
| Valsartan | 13 | $120 | $9 |
| Methadone | 12 | $117 | $10 |
| Isosorbide Mononitrate Er | 14 | $114 | $8 |
| Triamcinolone Acetonide | 16 | $99 | $6 |
| Bupropion Hcl Sr | 11 | $83 | $8 |
| Furosemide | 23 | $66 | $3 |
| Glimepiride | 12 | $65 | $5 |
| Carvedilol | 24 | $61 | $3 |
| Allopurinol | 13 | $60 | $5 |
| Lorazepam | 23 | $59 | $3 |
| Meloxicam | 25 | $49 | $2 |
| Hydrochlorothiazide | 33 | $38 | $1 |
| Simvastatin | 14 | $34 | $2 |
Year by year
| 2024 | 2,219 | 206 | 4% (77) | None | $230,162 |
| 2023 | 1,615 | 192 | 2% (30) | 17% | $268,074 |
| 2022 | 969 | 188 | 3% (33) | None | $119,293 |
| 2021 | 393 | 60 | None | None | $26,255 |
| 2020 | 255 | 67 | None | None | $16,032 |
| 2019 | 786 | 142 | 5% (39) | None | $86,295 |
| 2018 | 550 | 98 | None | None | $40,844 |
| 2017 | 742 | 129 | 2% (15) | 21% | $45,036 |
| 2016 | 509 | 104 | 4% (19) | None | $34,003 |
| 2015 | 69 | 17 | None | None | $6,096 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Jardiance | 39 | $42,452 | $1,089 |
| Ozempic | 32 | $32,550 | $1,017 |
| Lantus Solostar | 15 | $18,997 | $1,266 |
| Rybelsus | 13 | $15,347 | $1,181 |
| Incruse Ellipta | 15 | $6,581 | $439 |
| Xarelto | 11 | $6,419 | $584 |
| Symbicort | 15 | $5,729 | $382 |
| Diclofenac | 46 | $4,589 | $100 |
| Atorvastatin | 109 | $2,067 | $19 |
| Gabapentin | 43 | $1,611 | $37 |
| Albuterol Sulfate Hfa | 25 | $1,315 | $53 |
| Amlodipine Besylate | 94 | $1,248 | $13 |
| Ventolin Hfa | 18 | $1,194 | $66 |
| Fluticasone Propionate | 45 | $1,137 | $25 |
| Metformin Hcl Er | 46 | $967 | $21 |
| Losartan | 48 | $885 | $18 |
| Tamsulosin | 26 | $858 | $33 |
| Omeprazole | 36 | $810 | $22 |
| Chlorthalidone | 33 | $778 | $24 |
| Metformin | 61 | $711 | $12 |
| Lisinopril | 48 | $577 | $12 |
| Glipizide | 29 | $487 | $17 |
| Levothyroxine | 23 | $428 | $19 |
| Hydrocodone-Acetaminophen | 19 | $428 | $23 |
| Famotidine | 15 | $419 | $28 |
| Lisinopril-Hydrochlorothiazide | 15 | $396 | $26 |
| Allopurinol | 16 | $375 | $23 |
| Ibuprofen | 20 | $367 | $18 |
| Metoprolol | 41 | $354 | $9 |
| Clopidogrel | 20 | $312 | $16 |
| Cyclobenzaprine | 23 | $254 | $11 |
| Trazodone | 15 | $221 | $15 |
| Escitalopram | 11 | $217 | $20 |
| Spironolactone | 17 | $174 | $10 |
| Glimepiride | 23 | $141 | $6 |
| Pravastatin | 11 | $139 | $13 |
| Triamcinolone Acetonide | 11 | $138 | $13 |
| Alprazolam | 11 | $112 | $10 |
| Meloxicam | 15 | $109 | $7 |
| Hydrochlorothiazide | 22 | $68 | $3 |
| Furosemide | 13 | $47 | $4 |
2022: 25 drugs
| Spiriva Respimat | 14 | $7,476 | $534 |
| Diclofenac | 26 | $1,430 | $55 |
| Gabapentin | 33 | $1,321 | $40 |
| Atorvastatin | 70 | $884 | $13 |
| Albuterol Sulfate Hfa | 19 | $872 | $46 |
| Hydrocodone-Acetaminophen | 22 | $792 | $36 |
| Escitalopram | 11 | $621 | $56 |
| Amlodipine Besylate | 65 | $567 | $9 |
| Fluticasone Propionate | 30 | $475 | $16 |
| Metoprolol | 22 | $385 | $18 |
| Omeprazole | 23 | $301 | $13 |
| Lisinopril-Hydrochlorothiazide | 14 | $269 | $19 |
| Tamsulosin | 12 | $244 | $20 |
| Losartan | 29 | $235 | $8 |
| Lisinopril | 22 | $210 | $10 |
| Metformin | 19 | $208 | $11 |
| Levothyroxine | 13 | $186 | $14 |
| Spironolactone | 14 | $157 | $11 |
| Hydrochlorothiazide | 27 | $143 | $5 |
| Furosemide | 11 | $126 | $11 |
| Metformin Hcl Er | 13 | $121 | $9 |
| Clopidogrel | 11 | $112 | $10 |
| Meloxicam | 13 | $83 | $6 |
| Hydrocortisone | 11 | $76 | $7 |
| Alprazolam | 12 | $71 | $6 |
2021: 10 drugs
| Tolterodine Tartrate Er | 12 | $1,730 | $144 |
| Estradiol | 12 | $906 | $75 |
| Atorvastatin | 24 | $484 | $20 |
| Omeprazole | 13 | $319 | $25 |
| Amlodipine Besylate | 26 | $267 | $10 |
| Diclofenac | 12 | $252 | $21 |
| Losartan | 16 | $239 | $15 |
| Levothyroxine | 11 | $197 | $18 |
| Metformin | 12 | $155 | $13 |
| Hydrochlorothiazide | 20 | $108 | $5 |
2020: 5 drugs
| Omeprazole | 16 | $173 | $11 |
| Atorvastatin | 16 | $167 | $10 |
| Gabapentin | 11 | $141 | $13 |
| Amlodipine Besylate | 11 | $59 | $5 |
| Sertraline | 11 | $56 | $5 |
2019: 21 drugs
| Sensipar | 22 | $43,075 | $1,958 |
| Serevent Diskus | 15 | $5,943 | $396 |
| Atorvastatin | 57 | $894 | $16 |
| Oxybutynin Chloride Er | 18 | $598 | $33 |
| Gabapentin | 25 | $459 | $18 |
| Pantoprazole | 15 | $329 | $22 |
| Propranolol | 19 | $301 | $16 |
| Mupirocin | 15 | $290 | $19 |
| Hydrocodone-Acetaminophen | 15 | $255 | $17 |
| Lisinopril | 44 | $243 | $6 |
| Bupropion Hcl Sr | 13 | $224 | $17 |
| Trazodone | 12 | $175 | $15 |
| Omeprazole | 14 | $156 | $11 |
| Sertraline | 22 | $148 | $7 |
| Metoprolol | 15 | $96 | $6 |
| Hydroxyzine | 11 | $89 | $8 |
| Isosorbide Mononitrate Er | 11 | $88 | $8 |
| Hydrochlorothiazide | 11 | $87 | $8 |
| Metformin | 13 | $87 | $7 |
| Furosemide | 15 | $52 | $3 |
| Amlodipine Besylate | 15 | $33 | $2 |
2018: 12 drugs
| Lantus | 14 | $5,014 | $358 |
| Atorvastatin | 35 | $548 | $16 |
| Levothyroxine | 36 | $459 | $13 |
| Mirtazapine | 15 | $241 | $16 |
| Gabapentin | 15 | $219 | $15 |
| Amlodipine Besylate | 42 | $208 | $5 |
| Metformin | 22 | $179 | $8 |
| Omeprazole | 22 | $170 | $8 |
| Lisinopril | 27 | $165 | $6 |
| Metoprolol | 11 | $81 | $7 |
| Lovastatin | 12 | $67 | $6 |
| Alendronate | 11 | $43 | $4 |
2017: 20 drugs
| Lantus | 15 | $6,806 | $454 |
| Symbicort | 11 | $3,172 | $288 |
| Rosuvastatin | 18 | $1,281 | $71 |
| Desmopressin Acetate | 11 | $718 | $65 |
| Atorvastatin | 25 | $427 | $17 |
| Mirtazapine | 18 | $341 | $19 |
| Metformin | 38 | $274 | $7 |
| Omeprazole | 29 | $221 | $8 |
| Lisinopril | 41 | $187 | $5 |
| Tamsulosin | 12 | $177 | $15 |
| Gabapentin | 13 | $175 | $13 |
| Amlodipine Besylate | 20 | $150 | $7 |
| Levothyroxine | 20 | $138 | $7 |
| Fluticasone Propionate | 12 | $126 | $11 |
| Lovastatin | 24 | $116 | $5 |
| Losartan | 11 | $102 | $9 |
| Metoprolol | 16 | $93 | $6 |
| Furosemide | 20 | $89 | $4 |
| Alendronate | 16 | $86 | $5 |
| Lisinopril-Hydrochlorothiazide | 14 | $53 | $4 |
2016: 16 drugs
| Lantus | 19 | $8,750 | $461 |
| Xarelto | 11 | $5,533 | $503 |
| Levothyroxine | 16 | $255 | $16 |
| Atorvastatin | 19 | $249 | $13 |
| Nitroglycerin Patch | 11 | $246 | $22 |
| Metformin | 15 | $174 | $12 |
| Hydrocodone-Acetaminophen | 15 | $171 | $11 |
| Amlodipine Besylate | 12 | $139 | $12 |
| Trazodone | 11 | $96 | $9 |
| Lisinopril | 24 | $95 | $4 |
| Omeprazole | 14 | $88 | $6 |
| Clopidogrel | 17 | $63 | $4 |
| Metoprolol | 19 | $60 | $3 |
| Lovastatin | 12 | $52 | $4 |
| Carvedilol | 15 | $38 | $3 |
| Lisinopril-Hydrochlorothiazide | 18 | $29 | $2 |
Money from drug and device companies
$256 in 2025
| 2025 | 3 | 3 | None | $256 |
| 2024 | 2 | 2 | None | $120 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Mavyret | $120 | 1 payment
|
| Gilead Sciences | Descovy | $112 | 1 payment
|
| ViiV Healthcare | Apretude | $24 | 1 payment
|
See all 3 published payments
| ViiV Healthcare | Meals · 2025-07-09 | Apretude | $24 |
| Gilead Sciences | Meals · 2025-05-08 | Descovy | $112 |
| Abbvie | Meals · 2025-01-30 | Mavyret | $120 |
See earlier years (2024)
2024: $120
| Abbvie | Mavyret | $102 | 1 payment
|
| ViiV Healthcare | Rukobia | $18 | 1 payment
|
Professional record
- NPI
- 1255769857
- Licence
- CA A163302California A163302: Current · expires 2027-07-31
- Trained
- University of California, Davis School of Medicine, 2015
- Group
- Lifelong Medical Care · Sutter Bay Medical Foundation · UCSF Medical Group Business Services
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 2344 6th St, Berkeley, CA, 94710
- NPI first listed
- 2013-10-17
- NPI last updated
- 2023-06-12
- NPI record certified
- 2023-06-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2801 Daggett Ave, Klamath Falls, OR, 97601 · 2821 Daggett Ave Ste 100, Klamath Falls, OR, 97601 · 4610 X St, Sacramento, CA, 95817